CN1813928A - External-use drug of canavalia gladiata for traumatic injury and activating collaterals - Google Patents
External-use drug of canavalia gladiata for traumatic injury and activating collaterals Download PDFInfo
- Publication number
- CN1813928A CN1813928A CN 200510119631 CN200510119631A CN1813928A CN 1813928 A CN1813928 A CN 1813928A CN 200510119631 CN200510119631 CN 200510119631 CN 200510119631 A CN200510119631 A CN 200510119631A CN 1813928 A CN1813928 A CN 1813928A
- Authority
- CN
- China
- Prior art keywords
- traumatic injury
- radix
- external
- canavalia gladiata
- activating collaterals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000014674 injury Diseases 0.000 title claims abstract description 29
- 230000008736 traumatic injury Effects 0.000 title claims abstract description 27
- 239000003814 drug Substances 0.000 title claims abstract description 25
- 240000003049 Canavalia gladiata Species 0.000 title claims abstract description 11
- 235000010518 Canavalia gladiata Nutrition 0.000 title claims abstract description 11
- 230000003213 activating effect Effects 0.000 title claims description 15
- 229940079593 drug Drugs 0.000 title claims description 15
- 241000220451 Canavalia Species 0.000 claims description 3
- 201000010099 disease Diseases 0.000 abstract description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 13
- 201000003068 rheumatic fever Diseases 0.000 abstract description 8
- 230000001225 therapeutic effect Effects 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 abstract description 4
- 208000006820 Arthralgia Diseases 0.000 abstract 1
- 241000721153 Chloranthus japonicus Species 0.000 abstract 1
- 241000988333 Dendropanax dentiger Species 0.000 abstract 1
- 208000000112 Myalgia Diseases 0.000 abstract 1
- 241000205426 Persicaria filiformis Species 0.000 abstract 1
- 208000025747 Rheumatic disease Diseases 0.000 abstract 1
- 208000026137 Soft tissue injury Diseases 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000000552 rheumatic effect Effects 0.000 abstract 1
- 230000036407 pain Effects 0.000 description 17
- 239000008280 blood Substances 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 15
- 210000003205 muscle Anatomy 0.000 description 15
- 210000000988 bone and bone Anatomy 0.000 description 9
- 208000034656 Contusions Diseases 0.000 description 6
- 230000009519 contusion Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 210000004872 soft tissue Anatomy 0.000 description 6
- 206010052428 Wound Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 230000002040 relaxant effect Effects 0.000 description 5
- 210000002435 tendon Anatomy 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 206010024453 Ligament sprain Diseases 0.000 description 2
- 208000010040 Sprains and Strains Diseases 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a Daodougen Diedahuoluo medicine for external application for effectively curing the diseases of rheumatic arthritis, rheumatic arthrodynia, arthralgia and myalgia, soft tissue injury and traumatic injury, etc. with obvious therapeutic effect. It is made up by using 4 Chinese medicinal materials of canavalia gladiata root, chloranthus japonicus, dendropanax dentiger and antenoron filiforme root and adding white liquor through a certain preparation process. Its total effective rate is above 94%.
Description
Technical field:
The present invention relates to a kind of external-use drug of canavalia gladiata for traumatic injury and activating collaterals.
Background technology:
Traumatic injury, the Fengshi Guanjie disease is a kind of common disease, the people who from ancient times to the present suffers from this disease is a lot, is subjected to ailing the torment deeply, in the market the various traumatic injury of Xiao Shouing, Fengshi Guanjie disease medicine for external use is also a lot, but no matter be Western medicine or Chinese medicine, for this class Drug therapy traumatic injury, the slight illness of Fengshi Guanjie disease has played certain therapeutical effect really, but also there is not a kind of ideal treatment traumatic injury, the specific drug of Fengshi Guanjie disease.
Summary of the invention:
The inventor has a kind of treatment traumatic injury at above-mentioned weak point at pressing for of patient, the dispelling wind and removing obstruction in the collateral analgesic medicine for external use of Fengshi Guanjie disease; The inventor, verifies and by clinical trial repeatedly through research repeatedly, finally developed a kind of with low cost, prescription rationally, preparation is simple, very easy to use, it can be to traumatic injury, and the Fengshi Guanjie disease is carried out treating both the principal and secondary aspects of a disease, reaches good therapeutic effect.
Purpose of the present invention just provides a kind of external-use drug of canavalia gladiata for traumatic injury and activating collaterals.
Choice of drug Radix Canavaliae of the present invention, Herba chloranthi japonici, Radix Dendropanacis, Radix Antenoronis Filiformis, Chinese liquor (35-50 degree) are formed; Select Radix Canavaliae for use: have eliminating stasis to stop pain, relaxing muscles and tendons and activating QI and blood in the collateral; Control traumatic injury, soft tissue contusion, outer trauma muscle.Select Herba chloranthi japonici for use: have relaxing muscles and tendons and activating QI and blood in the collateral, dissipating blood stasis for subsidence of swelling; Control traumatic injury, wound swells and ache.Select Radix Dendropanacis for use: have expelling wind and removing dampness, relaxing muscles and tendons and activating QI and blood in the collateral, blood circulation promoting and blood stasis dispelling; Control traumatic injury, soft tissue contusion, old trauma, rheumatic arthritis.Select Radix Antenoronis Filiformis for use: have relaxing muscles and tendons and activating QI and blood in the collateral, expelling wind and removing dampness, promoting blood circulation to remove blood stasis, alleviating pain and detumescence; Dispelling the wind and dampness pathogens arthritis, traumatic injury wound, soft tissue contusion.Make the effect of each medicine produce collaborative effect above these drug regimens, to sprain the curative effect of disease of pain, bones and muscles pain, wound stasis of blood pain, rheumatism bones and muscles pain, rheumatic arthritis, soft tissue contusion definite thereby can realize effectively treating rheumatic arthritis, traumatic injury stasis of blood pain, traumatic injury, muscles and bones, and effect is better.
The consumption of drug component of the present invention also is to carry out a large amount of solid lines through the inventor to grope to sum up and draw, and each amounts of components is for all to have better therapeutic effect in the following weight parts scope; It is made up of the component of following weight portion:
Radix Canavaliae 1-55 part, Herba chloranthi japonici 1-55 part, Radix Dendropanacis 1-40 part and Radix Antenoronis Filiformis 1-30 part, Chinese liquor (35-50 degree) 12-540 part.
Optimization formula of the present invention is:
20 parts of 40 parts of Radix Canavaliaes, 40 parts of Herba chloranthi japonicis, 30 parts of Radix Dendropanacis and Radix Antenoronis Filiformiss, 390 parts of Chinese liquor (35-50 degree).
A kind of external-use drug of canavalia gladiata for traumatic injury and activating collaterals of the present invention has relaxing muscles and tendons and activating QI and blood in the collateral, promoting blood circulation to remove blood stasis, an effect of the analgesia of dispeling the wind; Be applicable to that treatment rheumatic arthritis, traumatic injury stasis of blood pain, traumatic injury, muscles and bones sprain the disease of pain, bones and muscles pain, wound stasis of blood pain, rheumatism bones and muscles pain, rheumatic arthritis, soft tissue contusion; Be a kind of with low cost, prescription rationally, preparation is simple, very easy to use, compares better efficacy with existing similar medicine for external use curative effect.A kind of external-use drug of canavalia gladiata for traumatic injury and activating collaterals of the present invention was once done a large amount of clinical trials in early stage, inferior to over one hundred example on the patient treatment case before this, comprise being used for the treatment of the disease that rheumatic arthritis, traumatic injury stasis of blood pain, traumatic injury, muscles and bones are sprained pain, bones and muscles pain, wound stasis of blood pain, rheumatism bones and muscles pain, rheumatic arthritis, soft tissue contusion, do not see untoward reaction during the treatment; General patient's medication can be cured in 1-60 days, and total effective rate is more than 92%, and therapeutic effect is very good.
Using method:
This medicine is a medicine for external use, and oral administration is cleaned the affected part with hot water, dabs in the affected part with the drenched medicinal liquid of absorbent cotton, and affected part is wiped to generating heat for good every day 3-6 time.
The specific embodiment:
Describe embodiments of the invention below in detail:
Embodiment 1:
A kind of external-use drug of canavalia gladiata for traumatic injury and activating collaterals provided by the present invention is made up of the component of following weight portion; Radix Canavaliae 1-55 part, Herba chloranthi japonici 1-55 part, Radix Dendropanacis 1-40 part and Radix Antenoronis Filiformis 1-30 part, Chinese liquor (35-50 degree) 12-540 part.
Embodiment 2:
Optimization formula of the present invention is:
20 parts of 40 parts of Radix Canavaliaes, 40 parts of Herba chloranthi japonicis, 30 parts of Radix Dendropanacis and Radix Antenoronis Filiformiss, 390 parts of Chinese liquor (35-50 degree).
Preparation method of the present invention is: at first with above-mentioned Radix Canavaliae, Herba chloranthi japonici, Radix Dendropanacis, Radix Antenoronis Filiformis, single chopping respectively, to be mixed in proportion together after each single chopping, be placed in the container then, and allocate Chinese liquor (35-50 degree) into, stir in the sealed container of back, according to the modern Chinese medicine processing technology or soaked 7-20 days, the mixture solution after handling packed into by the required metering of client to get product in the bottle.
Claims (3)
1, a kind of external-use drug of canavalia gladiata for traumatic injury and activating collaterals is characterized in that: Radix Canavaliae, Herba chloranthi japonici, Radix Dendropanacis and Radix Antenoronis Filiformis are formed.
2, a kind of external-use drug of canavalia gladiata for traumatic injury and activating collaterals according to claim 1, it is characterized in that: the component by following weight portion is formed; Radix Canavaliae 1-55 part, Herba chloranthi japonici 1-55 part, Radix Dendropanacis 1-40 part and Radix Antenoronis Filiformis 1-30 part.
3, a kind of external-use drug of canavalia gladiata for traumatic injury and activating collaterals according to claim 1, it is characterized in that: the component by following weight portion is formed; 20 parts of 40 parts of Radix Canavaliaes, 40 parts of Herba chloranthi japonicis, 30 parts of Radix Dendropanacis and Radix Antenoronis Filiformiss.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510119631 CN1813928A (en) | 2005-11-24 | 2005-11-24 | External-use drug of canavalia gladiata for traumatic injury and activating collaterals |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510119631 CN1813928A (en) | 2005-11-24 | 2005-11-24 | External-use drug of canavalia gladiata for traumatic injury and activating collaterals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1813928A true CN1813928A (en) | 2006-08-09 |
Family
ID=36906360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510119631 Pending CN1813928A (en) | 2005-11-24 | 2005-11-24 | External-use drug of canavalia gladiata for traumatic injury and activating collaterals |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1813928A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102940760A (en) * | 2012-12-06 | 2013-02-27 | 山东新希望六和集团有限公司 | Traditional Chinese medicine composition for preventing and treating swine fever |
| CN104312868A (en) * | 2014-10-26 | 2015-01-28 | 童皖晋 | Preparation method of health wine |
-
2005
- 2005-11-24 CN CN 200510119631 patent/CN1813928A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102940760A (en) * | 2012-12-06 | 2013-02-27 | 山东新希望六和集团有限公司 | Traditional Chinese medicine composition for preventing and treating swine fever |
| CN102940760B (en) * | 2012-12-06 | 2014-06-18 | 山东新希望六和集团有限公司 | Traditional Chinese medicine composition for preventing and treating swine fever |
| CN104312868A (en) * | 2014-10-26 | 2015-01-28 | 童皖晋 | Preparation method of health wine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1742895A (en) | External-use medicine of Herba sarcandrae | |
| CN1813944A (en) | External-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals | |
| CN1813928A (en) | External-use drug of canavalia gladiata for traumatic injury and activating collaterals | |
| CN100506253C (en) | Collateral-flow-activating external-use medicine of Radix Seu Folium Clematidis Henryi for treating injuries by falls | |
| CN100420476C (en) | Collateral-flow-activating external-use medicine of Herba et Radix Inebriantis for treating injuries by falls | |
| CN1813898A (en) | External-use medicine of hayberry bark for traumatic injury and activating collaterals | |
| CN1813992A (en) | Radix-zauthoxyli-Plamispini external-use collateral-flow-activating medicine for treating injuries from falls | |
| CN1813907A (en) | External-use medicine of cordateleaf ainsliaea root for traumatic injury and activating collaterals | |
| CN1813864A (en) | External-use medicine of thickleaf croton root for traumatic injury and activating collaterals | |
| CN1813942A (en) | External-use drug of helwingia himalaicahook for traumatic injury and activating collaterals | |
| CN1813963A (en) | External medicine of Herbaet Rhizoma Begoniae cavalerei for treating traumatic injuries and activating collateral flows | |
| CN1813990A (en) | Cortex Berheridis Radicis external-use medicine | |
| CN1742816A (en) | Wujiaofeng root external-use medicine | |
| CN1813854A (en) | External-use medicine of herb of seguin cobelia for traumatic injury and activating collaterals | |
| CN1742801A (en) | Qianjinba external-use medicine | |
| CN1814016A (en) | Collateral-flow-activating external-use medicine of Fodium Desmoris for treating injuries from falls | |
| CN1813945A (en) | External-use drug of croton seed tree root for traumatic injury and activating collaterals | |
| CN1739693A (en) | Externally applied medicine of dunn tongoloa root | |
| CN1762469A (en) | Externally applied medicine of madeira vine | |
| CN1742907A (en) | External-use medicine of Radix celastri orbiculati | |
| CN1814063A (en) | Collateral-flow-activating external-use medicine of lysmachiae Grammicae for treating injuries by falls | |
| CN1739624A (en) | Externally applied medicine of aizoon stonecrop root | |
| CN1739711A (en) | Externally applied medicine of rhodiola root | |
| CN1742888A (en) | Fracture-treating medicated of Laoyahu | |
| CN1751709A (en) | External use medicine for treating traumatic injury |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |